Stereoselective pharmacokinetics of tetrahydropalmatine after oral administration of (-)-enantiomer and the racemate

被引:23
作者
Hong, ZY [1 ]
Fan, GR [1 ]
Chai, YF [1 ]
Yin, XP [1 ]
Wu, YT [1 ]
机构
[1] Mil Med Univ 2, Sch Pharm, Shanghai Key Lab Pharmaceut Metabolites Res, Shanghai 200433, Peoples R China
关键词
pharmacokinetics; chiral HPLC analysis; rac-tetrahydropalmatine; (-)-tetrahydropalmatine; THP;
D O I
10.1002/chir.20161
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Tetrahydropalmatine (THP) is a biologically active ingredient isolated from a traditional Chinese herb Rhizoma corydalis (yanhusuo). THP is a racemic mixture which contains 50% of the (+) and 50% of (-) enantiomer. The (-) enantiomer accounts for most of the analgesic effects. Plasma concentrations of THP enantiomers were analyzed by chiral high-performance liquid chromatography (HPLC) on a Chiralcel OJ column with quantification by UV at 230 nm. The method was used to determine the pharmacokinetics of THP enantiomers in rats and dogs after oral administration of rac-THP or (-)-THP. The pharmacokinetic profiles of the two enantiomers after dosing with rac-THP were significantly different both in rats and dogs. The mean C-max and AUC(0-infinity) values in rats were 1.93 +/- 0.36 mu g/ml and 6.65 +/- 2.34 mu g(.)h/ml for the (-) enantiomer, and 1.11 +/- 0.25 mu g/ml and 2.03 +/- 0.45 mu g(.)h/ml for the (+) enantiomer. The mean C-max and AUC(0-infinity) in dogs were 1.60 +/- 0.81 mu g/ml and 9.88 +/- 2.58 mu g(.)h/ml for the (-) enantiomer, while 0.36 +/- 0.21 mu g/ml and 1.22 +/- 0.40 mu g(.)h/ml for the (+) enantiomer. rac-THP at 40 mg/kg and (-)-THP at 20 mg/kg had very similar plasma concentration-time profiles, and C-max, AUC(0-infinity) and t(1/2) of the (-) enantiomer in both rats and dogs, indicating that the two treatments were equivalent with respect to the pharmacokinetic properties of the (-) enantiomer. (c) 2005 Wiley-Liss, Inc.
引用
收藏
页码:293 / 296
页数:4
相关论文
共 12 条
[1]   NONCHIRAL, HOMOCHIRAL AND COMPOSITE CHIRAL DRUGS [J].
ARIENS, EJ .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1993, 14 (02) :68-75
[2]   STEREOCHEMICAL ASPECTS OF PHARMACOTHERAPY [J].
BROCKS, DR ;
JAMALI, F .
PHARMACOTHERAPY, 1995, 15 (05) :551-564
[3]   Pharmacological importance of stereochemical resolution of enantiomeric drugs [J].
Islam, MR ;
Mahdi, JG ;
Bowen, ID .
DRUG SAFETY, 1997, 17 (03) :149-165
[4]   ENANTIOSELECTIVE ASPECTS OF DRUG-ACTION AND DISPOSITION - THERAPEUTIC PITFALLS [J].
JAMALI, F ;
MEHVAR, R ;
PASUTTO, FM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (09) :695-715
[5]  
JIN GZ, 1986, SCI CHINA SER B, V29, P1054
[6]  
JIN Z, 1987, ACTA PHARMACOL SINIC, V22, P472
[7]  
*PHARM COMM RPC, 2000, CHIN PHARM 1, P216
[8]  
Sha S., 1985, ASSAY METHODS ACTIVE, P53
[9]   ENANTIOMER SPECIFIC PHARMACOKINETICS [J].
TUCKER, GT ;
LENNARD, MS .
PHARMACOLOGY & THERAPEUTICS, 1990, 45 (03) :309-329
[10]  
WANG YS, 1993, CHINESE PHARMACOL B, V9, P358